Bank of America’s Pacira BioSciences PCRX Stock Holding History

Bank of America’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-72,600	Closed	-$3.57M	–	7305
2018 Q3	$3.57M	Hold	72,600	–	–	﹤0.01%	3495
2018 Q2	$2.33M	Sell	72,600 -104,400	-59%	-$3.6M	﹤0.01%	3859
2018 Q1	$5.51M	Buy	177,000 +141,400	+397%	+$5.03M	﹤0.01%	2996
2017 Q4	$1.63M	Buy	35,600 +10,600	+42%	+$420K	﹤0.01%	4129
2017 Q3	$939K	Sell	25,000 -1,500	-6%	-$60.4K	﹤0.01%	4558
2017 Q2	$1.26M	Sell	26,500 -24,500	-48%	-$1.14M	﹤0.01%	4265
2017 Q1	$2.33M	Buy	51,000 +31,500	+162%	+$1.36M	﹤0.01%	3742
2016 Q4	$630K	Buy	+19,500	New	+$651K	﹤0.01%	4658
2016 Q3	–	Sell	-80,600	Closed	-$2.72M	–	7298
2016 Q2	$2.72M	Sell	80,600 -69,400	-46%	-$3.41M	﹤0.01%	3369
2016 Q1	$7.95M	Sell	150,000 -17,500	-10%	-$1.02M	﹤0.01%	2357
2015 Q4	$12.9M	Buy	167,500 +135,000	+415%	+$7.64M	﹤0.01%	2038
2015 Q3	$1.34M	Buy	32,500 +5,200	+19%	+$318K	﹤0.01%	4110
2015 Q2	$1.93M	Buy	27,300 +15,000	+122%	+$1.18M	﹤0.01%	3504
2015 Q1	$1.09M	Buy	+12,300	New	+$1.25M	﹤0.01%	3715
2014 Q2	–	Sell	-8,000	Closed	-$560K	–	8159
2014 Q1	$560K	Sell	8,000 -15,000	-65%	-$1.02M	﹤0.01%	4488
2013 Q4	$1.32M	Buy	+23,000	New	+$1.21M	﹤0.01%	3758

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America's PCRX Position: Q1 2026 in Review

Bank of America increased its Pacira BioSciences (PCRX) stake by 2% in Q1 2026, buying an estimated $80.7K and bringing the position to 188,437 shares worth $4.26M. The position accounts for ﹤0.01% of the portfolio, ranked #3591.

Bank of America first reported a position in PCRX in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.5M in Q1 2024. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

Bank of America held 188,437 shares of Pacira BioSciences worth $4.26M as of Q1 2026.
Bank of America bought 3,630 Pacira BioSciences shares in Q1 2026, an estimated $80.7K.
Pacira BioSciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3591 holding.
Bank of America first reported a position in Pacira BioSciences in Q2 2013 and has held it in 52 quarters since.
Bank of America's Pacira BioSciences position peaked at $17.5M in Q1 2024.
241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.